Navidea Biopharmaceuticals Inc FCF yield
What is the FCF yield of Navidea Biopharmaceuticals Inc?
The FCF yield of Navidea Biopharmaceuticals Inc is -13.92%
What is the definition of FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc
What does Navidea Biopharmaceuticals Inc do?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Companies with fcf yield similar to Navidea Biopharmaceuticals Inc
- Ampio Pharmaceuticals Inc has FCF yield of -13.96%
- UPM-Kymmene Oyj has FCF yield of -13.95%
- iRobot has FCF yield of -13.95%
- Goldstar Minerals has FCF yield of -13.94%
- ScoZinc Mining has FCF yield of -13.93%
- Hertz Global has FCF yield of -13.93%
- Navidea Biopharmaceuticals Inc has FCF yield of -13.92%
- Integra Resources has FCF yield of -13.91%
- Integra Resources has FCF yield of -13.91%
- Marvel Discovery has FCF yield of -13.90%
- Microba Life Sciences Ltd has FCF yield of -13.89%
- Emperor has FCF yield of -13.89%
- Perma-Fix Environmental Services has FCF yield of -13.88%